Sulfamethizole

CHEMBL1191 Phase 4 Aprobado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
270.3 g/mol
LogP
0.5
Phase
4

Sulfamethizole is a short-acting sulfonamide antibiotic with high urinary concentrations used specifically for the treatment of uncomplicated urinary tract infections caused by susceptible gram-positive and gram-negative bacteria. Its rapid renal excretion achieves high antibacterial concentrations in urine, making it particularly suited for lower urinary tract infections. Like all sulfonamides, it inhibits bacterial dihydropteroate synthase to block folate synthesis.

Peso molecular

270,3000 g/mol

LogP

0,50

TPSA

135,00 Ų

Regla de cinco de Lipinski

Cumple

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estructura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

Cc1nnc(NS(=O)(=O)c2ccc(N)cc2)s1

InChI

InChI=1S/C9H10N4O2S2/c1-6-11-12-9(16-6)13-17(14,15)8-4-2-7(10)3-5-8/h2-5H,10H2,1H3,(H,12,13)

Molecular Formula

C9H10N4O2S2

HBD / HBA

2 / 7

Enlaces Rotables

3

Átomos Pesados

17

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Preguntas frecuentes

Sulfamethizole is a short-acting sulfonamide antibiotic with high urinary concentrations used specifically for the treatment of uncomplicated urinary tract infections caused by susceptible gram-positive and gram-negative bacteria. Its rapid renal excretion achieves high antibacterial concentrations in urine, making it particularly suited for lower urinary tract infections. Like all sulfonamides, it inhibits bacterial dihydropteroate synthase to block folate synthesis.

Yes, Sulfamethizole is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1191. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 5328. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.